Skip to main content

Together we are beating cancer

Donate now

Institute

Showing 12 out of 61 results

As the roof goes on our brand new Cancer Research UK Manchester Institute following a devastating fire in 2017, we hear from one of the PhD students who lived through it. As the roof goes on our brand new Cancer Research UK Manchester Institute following a devastating fire in 2017, we hear from one of the PhD students who lived through it.

by Emily Armstrong | In depth | 1 November 2021

1 November 2021

prostate cancer biopsy
  • Science & Technology
  • Health & Medicine

Targeted prostate cancer screening: Are we there yet?

Prostate cancer screening is back in the news, as results from a targeted screening programme are released. But when it comes to yearly checks, are we there yet? Prostate cancer screening is back in the news, as results from a targeted screening programme are released. But when it comes to yearly checks, are we there yet?

by Katie Roberts | Analysis | 20 October 2021

20 October 2021

We speak to Professor Shankar Balasubramanian about his work on NGS, his incredible translational journey and the power of the pub… We speak to Professor Shankar Balasubramanian about his work on NGS, his incredible translational journey and the power of the pub…

by Phil Prime | Interview | 15 October 2021

15 October 2021

That Cancer Conversation in a white speech bubble with a dark blue background

From groundbreaking rare cancer research to ending up on Forbes 30 under 30, we chat to Sigourney Bell about her work in the lab and her global organisation, Black in Cancer. From groundbreaking rare cancer research to ending up on Forbes 30 under 30, we chat to Sigourney Bell about her work in the lab and her global organisation, Black in Cancer.

by Cancer Research UK | Podcast | 8 October 2021

8 October 2021

This entry is part 3 of 26 in the series That Cancer Conversation
Prostate cancer cells
  • Science & Technology
  • Health & Medicine

Combining existing drugs improves prostate cancer survival

Adding abiraterone to standard hormone therapy improves survival for men with high-risk prostate cancer, according to findings presented at the ESMO conference. Adding abiraterone to standard hormone therapy improves survival for men with high-risk prostate cancer, according to findings presented at the ESMO conference.

by Cancer Research UK | News | 19 September 2021

19 September 2021

Hand holding a Cytosponge pill next to an image of a slide with stained cells

Cancer Research UK-funded researchers have developed a tool to help experts diagnose a condition that can increase the risk of developing oesophageal cancer. Cancer Research UK-funded researchers have developed a tool to help experts diagnose a condition that can increase the risk of developing oesophageal cancer.

by Cancer Research UK | News | 15 April 2021

15 April 2021

A snapshot of a single mouse skin cancer cell as it slides along a petri dish.

Our scientists at the Beatson Institute are using powerful microscopes to zoom in on how cancer cells move. Our scientists at the Beatson Institute are using powerful microscopes to zoom in on how cancer cells move.

by Rupal Mistry | Analysis | 16 March 2020

16 March 2020

This entry is part 29 of 30 in the series Science Snaps
Cancer-associated fibroblasts stained to reveal their DNA (blue) and structural proteins (red).

Scientists are intercepting conversations between supporting cells and blood vessels that could help cancer spread. Scientists are intercepting conversations between supporting cells and blood vessels that could help cancer spread.

by Harry Jenkins | Analysis | 24 January 2020

24 January 2020

This entry is part 28 of 30 in the series Science Snaps